We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$349B
AUM Growth
-$1.04B
Cap. Flow
+$12.6B
Cap. Flow %
3.6%
Top 10 Hldgs %
18.46%
Holding
3,713
New
104
Increased
2,394
Reduced
623
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Healthcare 12.31%
3 Financials 11.79%
4 Consumer Discretionary 9.84%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVBF icon
2926
MVB Financial
MVBF
$399M
$690K ﹤0.01%
30,555
PSTL
2927
Postal Realty Trust
PSTL
$698M
$689K ﹤0.01%
51,072
-15,609
-23% -$226K
FSBC icon
2928
Five Star Bancorp
FSBC
$1.14B
$684K ﹤0.01%
34,106
VYGR icon
2929
Voyager Therapeutics
VYGR
$181M
$683K ﹤0.01%
88,173
+3,118
+4% +$28.5K
METC icon
2930
Ramaco Resources Class A
METC
$581M
$683K ﹤0.01%
64,210
ARAY icon
2931
Accuray
ARAY
$32.2M
$680K ﹤0.01%
249,865
XERS icon
2932
Xeris Biopharma Holdings
XERS
$1.4B
$679K ﹤0.01%
365,013
IAUX
2933
i-80 Gold Corp
IAUX
$1.16B
$676K ﹤0.01%
441,666
ALXO icon
2934
ALX Oncology
ALXO
$260M
$676K ﹤0.01%
140,734
-24,817
-15% -$135K
IWP icon
2935
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
$675K ﹤0.01%
+7,393
New +$707K
CVGI icon
2936
Commercial Vehicle Group
CVGI
$156M
$674K ﹤0.01%
86,851
OCUL icon
2937
Ocular Therapeutix
OCUL
$1.84B
$673K ﹤0.01%
214,415
RGTI icon
2938
Rigetti Computing
RGTI
$5.33B
$672K ﹤0.01%
505,189
+86,613
+21% +$166K
WKHS icon
2939
Workhorse Group
WKHS
$34M
$669K ﹤0.01%
538
+178
+49% +$458K
CIVB icon
2940
Civista Bancshares
CIVB
$607M
$662K ﹤0.01%
42,738
+1,636
+4% +$28.4K
MCBC
2941
DELISTED
Macatawa Bank Corp
MCBC
$660K ﹤0.01%
73,650
+2,964
+4% +$27.7K
ML
2942
DELISTED
MoneyLion Inc.
ML
$660K ﹤0.01%
30,476
+10,116
+50% +$167K
GNTY
2943
DELISTED
Guaranty Bancshares
GNTY
$656K ﹤0.01%
22,855
OVID icon
2944
Ovid Therapeutics
OVID
$435M
$653K ﹤0.01%
170,036
+7,389
+5% +$26.6K
LBC
2945
DELISTED
Luther Burbank Corporation Common Stock
LBC
$653K ﹤0.01%
77,696
+2,117
+3% +$19.6K
SCU
2946
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$652K ﹤0.01%
56,246
-8,588
-13% -$94.1K
AURA icon
2947
Aura Biosciences
AURA
$728M
$652K ﹤0.01%
72,723
URGN icon
2948
UroGen Pharma
URGN
$1.88B
$650K ﹤0.01%
46,394
+1,670
+4% +$26.8K
GMAB icon
2949
Genmab
GMAB
$17.6B
$647K ﹤0.01%
18,340
+10,891
+146% +$415K
ACRV icon
2950
Acrivon Therapeutics
ACRV
$66.8M
$647K ﹤0.01%
67,661
+6,703
+11% +$77.4K

Similar funds

Charles Schwab's Q3 2023 Portfolio in Review

As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.

  • Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
  • Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
  • Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
  • Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
  • Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
  • Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
  • Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.